The Korea Biomedicine Industry Association (KoBIA) is a key institution representing the biopharmaceutical industry in Korea. Established in 2011, KoBIA aims to foster the growth and development of the biopharmaceutical sector through comprehensive support, including policy advocacy, industry information dissemination, and facilitating collaboration between government and industry stakeholders. KoBIA provides services such as customized support, testing, method development, and promoting global competitiveness of Korean biopharmaceutical companies.